Business Context and Reporting Period
This is a Quarterly Report (Form 10-Q) for KLA Instruments Corporation for the period ended December 31, 1993. The company operates in the semiconductor equipment industry, specifically focusing on wafer inspection, metrology, and prober divisions. The report covers the second quarter and first six months of fiscal year 1994.
Key Financial Metrics
| Metric (in thousands) | 3 Months Ended Dec 31, 1993 | 6 Months Ended Dec 31, 1993 |
|---|---|---|
| Net Sales | $57,087 | $108,991 |
| Net Income | $6,292 | $10,458 |
| Income from Operations | $8,513 | $14,394 |
| Gross Margin | 43% | 42% |
| Cash and Cash Equivalents | $47,106 (Dec 31, 1993) | $47,106 (Dec 31, 1993) |
| Long-Term Debt | $20,000 | $20,000 |
| Current Portion of Debt | $1,685 | $1,685 |
| Net Income Per Share | $0.30 | $0.50 |
Material Changes vs. Prior Period
- Revenue Growth: Net sales increased 48% for the quarter and 41% for the six-month period compared to the prior fiscal year. This was driven by a substantial rise in unit shipments of the 2100 series wafer inspection products and growth in metrology and prober divisions.
- Profitability: Net income surged from $1,369 to $6,292 (quarterly) and from $1,940 to $10,458 (six-month). Operating income increased from $2,442 to $8,513 (quarterly).
- Margins: Gross margins improved significantly to 43% (quarterly) and 42% (six-month) from 35% and 34% in the prior year, attributed to manufacturing efficiencies and a favorable product mix.
- International Sales: International sales share rose to 66% (quarterly) and 64% (six-month) from 58% and 59% previously, due to a recovery in the Japanese semiconductor equipment industry.
- Expense Management: Engineering, research, and development expenses decreased as a percentage of sales (8.5% vs 10.8% quarterly) despite higher absolute spending, due to revenue growth. Selling, general, and administrative expenses remained stable at approximately 20% of sales.
Guidance, Outlook, and Risks
- Liquidity: Cash and cash equivalents decreased by $5 million to $47 million during the six-month period. Operating cash flow was negative ($2 million used) primarily due to a $13 million increase in accounts receivable, which outpaced net income.
- Capital Raise: In February 1994 (post-period), the company raised approximately $68 million via a public offering of 2.3 million new shares to fund general corporate purposes.
- Outlook: Future results depend on the ability to introduce new products, forecast demand accurately, and manage transitions from older products. Results may fluctuate due to competitor actions, foreign exchange rates, and semiconductor market conditions.
- Risks and Contingencies:
- Legal Proceedings: A claim against Orbot is scheduled for trial in September 1994. The Lemelson patent issue remains a contingency (refer to prior filings).
- Tax Assets: Management maintains a valuation allowance on deferred tax assets due to uncertainty regarding their realization.
Investor Verification Checklist
- Verify the sustainability of the 48% revenue growth and the specific demand for the 2100 series products in the upcoming quarters.
- Monitor the collection of accounts receivable, which increased by $13 million and contributed to negative operating cash flow.
- Review the status of the Orbot litigation and the Lemelson patent issue for potential financial impact.
- Assess the utilization of the $68 million raised in the February 1994 stock offering.
- Confirm the realization of deferred tax assets and the continued necessity of the valuation allowance.